Assessment of the endothelial function with changed volume of brachial artery by menstrual cycle by Shing-Hong Liu et al.
Assessment of the endothelial function 
with changed volume of brachial artery 
by menstrual cycle
Shing‑Hong Liu1, Jia‑Jung Wang2, Da‑Chuan Cheng3*, Chun‑Hung Su4,5* and Tzu‑Hsin Lin6
Background
Endothelial dysfunction is considered an important factor to estimate the risk of athero-
sclerosis, hypertension, and heart failure [1–3]. Several measurement techniques have 
been used to assess the endothelium-dependent vasodilation, which includes the coro-
nary epicardial vasoreactivity, coronary microvascular function, flow-mediated vasodi-
lation (FMD), and peripheral arterial tonometry (PAT) [3–5]. Some studies have been 
proposed for intima-media thickness measurement [6, 7]. Currently, the most widely 
used noninvasive technique to assess endothelial dysfunction is the FMD ratio of the 
brachial artery, which was first introduced in 1992 [8]. The diameter changes of the 
brachial artery are induced by the hyperemia stimulus as a result of the mediated local 
endothelial releasing the nitric oxide (NO) [9, 10]. In order to create the hyperemia stim-
ulus, a sphygmomanometer cuff is placed on the forearm. Then, the cuff inflates to the 
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supra-systolic pressure to occlude the blood flow of the brachial artery in a standardized 
time that causes consequent ischemia dilation of the downstream obstructed vessels. 
Afterward, the cuff deflates and induces a brief high-flow state that causes the dilation of 
brachial artery.
The most used method to assess the FMD ratio is brachial-artery ultrasound scan-
ning (BAUS), which requires a two-dimensional imaging process algorithm, an 
synchronous electrocardiogram monitor and a broadband linear array transducer (mul-
tiple-frequency: 7–14 MHz) [9, 10]. However, this method has some problems that must 
be overcome. The diameter of the brachial artery is measured from the continuous two-
dimensional gray-scale imaging, which must have the clear anterior and posterior inti-
mal interface between the lumen and the vessel wall. Thus, the linear array transducer 
must have good resolution [9]. Moreover, an individual training in the principles and 
technical skills of ultrasonography would affect the performance of the FMD measure-
ment because the maximal diameter occurs approximately at 45–60 s after the hyper-
emic stimulus. The operator has to do the training in the technique who could get the 
high quality and consistency in the FMD measurement [11, 12]. Thus, Corretti et  al. 
applied a training protocol for the ultrasound method [9].
In recent years, the measurement of the peripheral vasodilator response with fingertip 
PAT technology (EndoPAT, Israel) has been used to assess the endothelial dysfunction 
[8–10]. Although the fingertip PAT signal is interfered by various local, systemic, and 
environmental factors, this parameter is also affected by the bioavailability of NO; there-
fore, it also depends on the endothelial function [13–15]. The advantage of this method 
is its ease of use for the subjects, but it also requires a sphygmomanometer cuff placed 
at the forearm to create a hyperemic stimulus. In order to obtain a maximum volume 
change by the photoplethysmography, the finger-mounted probes include a system of 
inflatable neoprene membranes within a rigid external case to apply a counter-pressure 
(approximately 70  mmHg) for the finger. Thus, the change of finger arterial volume 
could be easier measured.
Moreover, Kuvin et  al. compared the accuracy between PAT and BAUS for subjects 
with high risks of endothelium dysfunction. The results showed a significant correlation 
between the two parameters [15]. Some studies have proven that the postmenopausal 
women supplying the ovarian hormones could decrease the occurrence of atheroscle-
rosis [16, 17]. Thus, Hashimoto et al. used the BAUS to assess the FMD of 17 volunteer 
women in three different phases of one menstrual cycle. They had shown that ovarian 
hormones could have a positive effect to reduce the endothelial dysfunction in humans. 
[18].
The changes of peripheral arterial volume are used to assess the endothelial function 
whether with BAUS or PAT methods. However, how to easily detect the change of arte-
rial volume is still a challenge. Liu et  al. proposed a method of constructing the “cuff 
model” that could detect the change of arterial volume by a sphygmomanometer cuff 
[19]. Moreover, they also compared the correlation of the changed volume measured by 
the cuff model and BAUS. The results showed that two methods have a high consistency 
[20]. Therefore, the goal of this study is to measure the FMD with this method which 
only uses one sphygmomanometer cuff to create the hyperemic stimulus and measure 
the FMD ratio. We also proposed a method to extract stable volume amplitudes and the 
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maximum volume amplitude from the continuous waveform before and after the hyper-
emia stimulus. Twenty-six female volunteers participated in this study for two complete 
menstrual cycles. In one menstrual cycle, we measured the participants’ FMD ratios in 
the menstrual phase and luteal phase and compared the difference.
Methods
The mechanism of our measurement system was based on a digital blood pressure 
monitor. The measurement system first measured the blood pressure and subsequently 
measured the FMD ratio. We will describe the experimental protocol in “Experimental 
protocol” section.
Hardware
Our system had a pressure sensor and a flow sensor. Both the pressure sensor (MPM 
100, range: 0–300 mmHg, resolution: 16 bits, Metrodyne Microsystem Corp., Taiwan) 
and the flow sensor (MFS 100, range: 0.3 to 2 l/minute, resolution: 12 bits, Metrodyne 
Microsystem Corp., Taiwan) were digital [20]. A TI MSP 430 F6736IPZ was used to per-
form the peripheral interface control and detect the cuff pressure and cuff volume [20]. 
The sampling rate was 125  Hz. The systolic and diastolic pressures could be detected 
using our designed instrument in one measurement. Moreover, the measured signals 
from the sensors during the inflating and deflating cycles were transmitted to a note-
book computer by bluetooth.
Volume of the brachial artery
In the oscillometric measurement, Liu et al. used a pressure sensor and a flow sensor 
to construct the cuff model (Ccuff) during the inflating cycle [19]. According to the cuff 
model, the pulse pressure (Pwave), extracted from the pulse signal of the cuff pressure 
could be transferred to the pulse volume (Vwave). Equation (1) shows the transfer under a 
cuff pressure (Pcuff),
FMD ratio
In Fig. 1, the red line shows Pcuff in the duration of the baseline and the black line shows 
Pcuff in the duration of the hyperemia reaction for one subject. Moreover, only the ampli-
tude of Vwave (ΔV) needs to be detected in the measurement of FMD ratio. Thus, the 
Pwave signals were filtered from the Pcuff signals in the durations of the baseline and 
hyperemia reaction as shown in Fig. 2a, b, respectively. The order of the high-pass filter 
was one, and its cutoff frequency was 0.5 Hz. The order of the low-pass filter was two, 
and its cutoff frequency was 40 Hz. The filtered pressure waveforms Then, according to 
Eq. (1), Pwave was transferred to Vwave. Figure 3 shows the Vwave signals in the duration of 
the baseline and hyperemia reaction.
The Pcuff was remained stable at a fixed pressure, the first phase was to search the 
maximum amplitude of the pulse volume in the duration of the hyperemia reaction 
(ΔVhyperemia) and the cuff pressure of ΔVhyperemia was marked. The second phase was to 
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duration of the baseline. The average of five consecutive stable amplitudes of pulse vol-
ume was defined as the baseline (ΔVbaseline) for the FMD measurement.
To avoid extracting a false Vwave, we defined a true Vwave as having an evident exponen-
tial decay in a diastolic duration [21, 22] and a limited difference between the systolic 
starting point and the diastolic ending point. Figure  4 shows the signal at 45–65  s of 
Fig. 3b in more detail. Although there is maximum amplitude at the 48th second, which 
is marked with a yellow rectangle, the Vwave value of this beat was affected by the body 
Fig. 1 The Pcuff signals before (black) and after (red) the hyperemic reaction
Fig. 2 The filtered Pwave signals from Fig. 1, a before, b after hyperemic reaction
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motion because its difference between the systolic starting point and the diastolic ending 
point (marked with red circles) is notably large. The truth maximum amplitude occurs at 
the 60th second, which is marked with a green rectangle.
The normalized difference of two neighboring truth amplitudes of pulse volume is 
defined as follows,
where n is the nth beat. Then, we defined the stable ΔV(n) as ΔVdiff within ±10 %. The 
volume FMD ratio is defined as follows,
(2)�Vdiff =
2[�V (n) −�V (n− 1)]









Fig. 3 The Vwave signals transferred from Fig. 2
Fig. 4 The detailed Vwave signal from the red range of Fig. 3b, a false Vwave is marked by a yellow rectangular 
mark, a truth Vwave is marked by a green rectangular mark
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Experimental protocol
Subjects
The FMD ratio was assessed using our method for 26 voluntary women with ages of 
26.3 ± 10.0 years (mean ± SD; range: 19–45 years), all of whom were healthy students 
and staff members of the school, and did not eat any oral contraceptives. We follow the 
protocol in [18] to select our female subjects. These female subjects had regular men-
strual cycles (26–35 days) for more than 3 months before this study [18]. They were not 
pregnant and were normotensive, non-diabetic, and nonsmoking during this study. The 
subject provided written informed consent before participating in this study after thor-
ough explanation of the study design and protocol.
Study design
Each female subject has been measured two times for two cycles in one menstrual cycle. 
The menstrual phase M and luteal phase L were examined per cycle. In the menstrual 
phase, the FMD was measured on the second day of menstruation. The luteal phase was 
defined as 5–7 days after an obvious increase of morning body temperature. To estimate 
their menstrual cycles, the participants checked their body temperature every morning. 
According to the method described by Corretti et al. the subjects did not eat or drink 
caffeine, high-fat foods, intake vitamin C or use tobacco for at least 4–6  h before the 
study [9]. Thus, we asked the subjects to measure the FMD before breakfast. If a subject 
ate breakfast, we canceled the measurement and asked her to return for measurement 
the next day. If a participant failed twice, the measurement of her menstrual cycle was 
not possible. Therefore, only 23 subjects finished the FMD measurement for both men-
strual cycles.
Measurement of FMD ratio
The study was performed according to the method described by Corretti et al. in a quiet 
and temperature-controlled (22–23 °C) room [9]. The examinations were conducted by 
the same examiner throughout this study. The subjects sat on a chair, and their left arm 
was placed on the table, as with the blood pressure measurement. Because our designed 
device could directly detect blood pressure, the FMD-measuring procedure was auto-
mated as shown in Fig. 5. The first row is the duration of each stage. The second row 











2 minutes 2 minutes5 minutes3 minutes
0 mmHg 50 mmHg 50 mmHgSystolic Pressure
+ 50 mm Hg
Dynamic
Stage 1 Stage 2 Stage 3 Stage 4
Fig. 5 The time sequence of the FMD measurement, the first row is the spending time, the second row is the 
Pcuff, and the third row is the functions of this system in the different stages
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the various stages. Subjects were required to rest for approximately 3  min before the 
measurement. First, the blood pressure of the subject was measured whose systolic pres-
sure was used to set the cuff pressure for occluding the blood flow. Then, the subject 
rested for 3  min in the first stage. In the second stage, the cuff was inflated to about 
50  mmHg, and the pulse volume signal was recorded for 2  min. The blood flow was 
occluded for 5 min in the third stage. The cuff was inflated to at least 50 mmHg above 
systolic pressure. In the fourth stage, the cuff was deflated to about 50 mmHg, and the 
pulse volume signal was recorded for 2 min. Figure 6 shows the real photos for FMD 
measurement, and Fig.  6a shows the procedure of blood pressure measurement. Fig-
ure  6b shows the procedure of the first stage, the time counts down from 180 to 0  s. 
Figure 6c shows the procedure of the second stage. The time counts down from 120 to 
0 s, and the cuff pressure is also displayed. Figure 6d, e show the procedures of third and 
fourth stages.
Results
The baseline data of the subjects’ variables are presented in Table 1. We used the paired 
t test to compare the information of each subject. The FMDvolume ratios in the luteal 


































Fig. 6 The real photo for FMD measurement, a blood pressure measurement, b stage 1, waiting 3 min, c 
stage 2, recording signal in 2 min, d stage 3, occluding blood flow for 5 min, e stage 4, recording signal in 
2 min
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(101.9 ±  45.5 and 91.4 ±  37.0  %), and there were significant differences between the 
menstrual and luteal phases (p = 0.0032 and p = 0.000). Figure 6a shows the bar graph 
of FMDvolume. However, the blood pressure of the subjects did not show any difference 
between the two phases. We considered the effect of the Pcuff difference between the 
baseline and hyperemia reaction stages on the assessment of FMD ratio. Figure 7 shows 
the correlation between the Pcuff difference and FMDvolume in the first menstrual cycle. 
Pcuff difference and FMDvolume did not have any correlation (M: p = 0.938, L: p = 0.836).
Discussions
In previous studies, the FMD ratio of the peripheral artery was usually assessed using 
the BAUS and PAT techniques [8–10, 13–15]. Moreover, the FMD induced by reactive 
hyperemia is known to depend on the presence of endothelial cells [4, 5, 23]. Therefore, 
a sphygmomanometer cuff was used to occlude the blood flow for the assessment of 
FMD ratio. To inflate the cuff to a supra-systolic pressure, these techniques must first 
measure the blood pressure of the subjects. Therefore, we combined the two functions, 
Table 1 Baseline hemodynamic data of  the important variables to  characterize the sub-
jects
Sys. systolic pressure, Dia. diastolic pressure, Temp. temperature
* p < 0.05, ** p < 0.005, *** p < 0.0001
a First cycle (M phase) vs second cycle (M phase), p = 0.374
b First cycle (L phase) vs second cycle (L phase), p = 0.432
First cycle (n = 26) Second cycle (n = 23)
M phase L phase p M phase L phase p
Age (years) 26.3 ± 10.0
BMI (kg/m2) 22.3 ± 1.8
Sys. (mmHg) 106.8 ± 8.9 105.5 ± 10.1 0.318 105.2 ± 8.6 106.9 ± 9.8 0.218
Dia. (mmHg) 68.2 ± 7.0 67.9 ± 7.9 0.725 67.6 ± 5.3 68.7 ± 7.2 0.444
Temp. (°C) 36.1 ± 0.51 36.4 ± 0.48 0.000*** 36.2 ± 0.31 36.5 ± 0.24 0.000***
FMDvolume (%) 101.9 ± 45.5a 137.5 ± 62.1b 0.0032** 91.4 ± 37.0a 124.0 ± 56.4b 0.000***

















p=0.0032                                   p=0.0001
Fig. 7 The bar graphs show the comparisons between the two phases in the two cycles
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assessment of FMD ratio and blood pressure measurements, in one instrument. The 
sphygmomanometer cuff not only was used to occlude the blood flow, but also to detect 
the amplitude of Vwave by the cuff model [19]. In order to evaluate the performance 
of our method, we follow the experiment protocol of Hashimoto et al. to measure the 
FMD ratios of 26 female subjects in the menstrual and luteal phases. The results also 
showed that the FMDvolume ratio in the luteal phase was the significant increase than the 
menstrual phase. The results were same as the study of [18]. Moreover, we designed the 
repeated measurement.
Some studies used the pressure waveform to assess the FMD ratio. Wu et  al. used 
the pulse pressure of radial artery to detect the FMD ratio for elderly diabetics [24, 25]. 
Using ensemble empirical mode decomposition, a significant signal for the response of 
FMD was extracted from the raw pulse pressure waveform. In their studies, Wu et al. 
used a sphygmomanometer cuff at the forearm to create the hyperemia stimulus. A wrist 
cuff, which was inflated at 40 mmHg, was used to record the pulse pressure waveform. 
But, according to the theorem of FMD measurement, the peripheral arterial volume or 
blood flow before and after the hyperemic stimulus would change. Although, the ampli-
tude of arterial volume waveform is proportional relation to the amplitude of arterial 
pressure waveform according to the arterial model [26, 27], the relation is a nonlinear 
function. When the transmural pressure is too high or low, the change of arterial pres-
sure waveform cannot represent the change of arterial volume waveform [28]. Therefore, 
the hypertension or hypotension subjects would not suggest using the pulse pressure 
waveform to assess the FMD ratio.
The disadvantage of using the cuff to detect the FMD ratio of the brachial artery is 
that it is difficult to remain Pcuff at a constant value because Pcuff is easily affected by 
motion artifacts. Pcuff in the baseline stage usually slowly decreases, possibly because 
the inner material of the cuff is polyvinyl chloride (PVC) or silicon, which is an elas-
tic material. When the cuff is tightly wound around the forearm, the inner layer of the 
cuff contacting with the skin has many folds on. The folds would slowly disappear when 
the cuff is inflated to a low pressure. Thus, the cuff volume increases, and the cuff pres-
sure decreases. To overcome this problem, the cuff is inflated again when Pcuff decreases 
to 46  mmHg, as shown in Fig.  1. In Fig.  1, Pcuff during the hyperemia reaction slowly 
increases and then decreases because the folds do not disappear when the cuff is quickly 
inflated to a higher pressure (above the systolic pressure). However, when Pcuff is deflated 
from the occluded stage to the hyperemia reaction stage, the cuff would slowly recover 
its elasticity and the folds disappear. But, in the hyperemia reaction stage, the cuff is not 
inflated again if Pcuff descends. Therefore, the Pcuff of the ΔVhyperemia beat was set as the 
target Pcuff for searching stable Vwave beats in the baseline duration. The Pcuff of stable 
Vwave beats must be the closest to the target pressure. Although, we had proved that the 
Pcuff difference did not correlate with the FMD ratio in Fig. 8, we believed that the Pcuff 
difference between the baseline and hyperemia reaction stages could not be large.
In Table 1, The FMDvolume ratio in the second menstrual cycle varied between the two 
phases more than in the first menstrual cycle (first vs. second: p = 0.0032 vs. p = 0.000), 
which may be the reason there were only 23 subjects in the second menstrual cycle. 
Moreover, the comparison of menstrual phase or luteal phase between two cycles did 
not have the significant difference, which implied that the two menstrual experiments 
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were independent. The temperature in the luteal phase was higher than in the menstrual 
phase regardless in the first cycle or the second cycle.
Atherosclerosis happening in the coronary artery and cerebral artery is very dangerous 
in the clinic. The endothelial dysfunction is a systemic condition [29]. According to Ross 
study, the vascular endothelial dysfunction is an initial step in the growth of atheroscle-
rosis [30]. Thus, some studies have reported that patients with atherosclerosis in the cor-
onary artery have the condition of the endothelial dysfunction in the brachial artery [31, 
32]. Therefore, although the assessing method of FMD ratio is applied only to superficial 
arteries, like as brachial artery and the femoral artery, it could be used to assess the car-
diovascular risk [5]. Now whether BAUS or EndoPat method could not be use by myself 
in the home. Thus, the advantage of using the cuff to detect the FMD ratio of brachial 
artery is that the digital blood pressure monitor could include the function of FMD ratio 
measurement and be operated by one person.
Conclusions
The vascular endothelial dysfunction is an initial step in the growth of atherosclerosis. 
Reactive-hyperemia-induced FMD is known to depend on endothelium. The purpose 
of our study is to design an FMD measurement system with the same mechanic struc-
ture as a commercial digital blood pressure monitor. Therefore, the system can measure 
blood pressure and assesses vascular endothelial function based on the FMD ratio in the 
patient’s home.
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